摘要
2019年12月份以来,我国新型冠状病毒肺炎(COVID-19)确诊病例急剧增加,引起全世界极大关注。面对严重的疫情,目前尚未发现特效药物,但一些中药复方在临床上显示出了明显的疗效,从这些中药复方中寻找和开发用于治疗COVID-19的天然药物具有较强的可行性。根据《新型冠状病毒肺炎诊疗方案(试行第六版)》中推荐使用的中药复方,对各复方中药材的使用频数进行统计,并对统计结果中高频数药材的抗病毒研究进展进行综述,以期为从中药中筛选抗新型冠状病毒(SARS-CoV-2)活性成分提供参考。
Since December 2019,there has been a sharp increase in the number of confirmed cases of pneumonia caused by the novel coronavirus(SARS-CoV-2)in China,which has caused great concern around the world.In face of severe epidemic,no specific drugs have been found in clinical practice.However,some Chinese medicine compounds have shown obvious clinical efficacy,and it is feasible to find and develop natural drugs for the treatment of novel coronavirus pneumonia from these compounds.In this paper,based on the recommends of new type of coronavirus infection pneumonia diagnosis and treatment scheme(trial version 6),the use frequency of Chinese herbal medicines was calculated.The antiviral reports of high frequency Chinese herbal medicines were reviewed,in order to provide the reference for screening the active components against SARS-CoV-2 from traditional Chinese medicine.
作者
邵仲柏
朱月霞
刘书豪
蒋凯俊
吴琦
沈金阳
刘玮炜
SHAO Zhong-bai;ZHU Yue-xia;LIU Shu-hao;JIANG Kai-jun;WU Qi;SHEN Jin-yang;LIU Wei-wei(Jiangsu Ocean University,Lianyungang 222000,China;Lianyungang Food and Drug Inspection and Testing Center,Lianyungang 222000,China)
出处
《中草药》
CAS
CSCD
北大核心
2020年第5期1153-1158,共6页
Chinese Traditional and Herbal Drugs
关键词
新型冠状病毒肺炎
新型冠状病毒
中药复方
高频数
中药
抗病毒
coronavirus pneumonia 2019
SARS-CoV-2
Chinese medicine compound
high frequency
Chinese materia medica
antiviral
